The cold pressor test during radionuclide ventriculography: A feasibility study in cancer patients

J. Verwey, A. Van Lingen, J. J. Teule, G. A K Heidendal, H. M. Pinedo

Research output: Contribution to journalArticle

Abstract

To monitor the use of cardiotoxic drugs, adequate assessment of myocardial function is required. Although serial radionuclide left ventricular ejection fraction (EF) studies allow a simple and rapid assessment of the myocardial function without risk or discomfort to the patient, they appear not to be sensitive enough. Determination of the EF during cold application may be more sensitive. In this study we tested the feasibility of the cold pressor test (CPT) in relation to EF determination in 23 cancer patients. Only minor side effects were recorded. The response of heart rate to cold was similar to the response reported in healthy volunteers and patients with coronary artery disease. In selected cases EF determination during CPT appeared to be more sensitive than EF at rest. EFCPT may be an attractive alternative for EFexercise in cancer patients who cannot perform enough exercise to stress cardiac function adequately, but for a more definite conclusion a prospective comparative study is required.

Original languageEnglish (US)
Pages (from-to)11-14
Number of pages4
JournalMedical Oncology and Tumor Pharmacotherapy
Volume3
Issue number1
DOIs
StatePublished - Mar 1986
Externally publishedYes

Fingerprint

Radionuclide Ventriculography
Feasibility Studies
Neoplasms
Radioisotopes
Stroke Volume
Coronary Artery Disease
Healthy Volunteers
Heart Rate
Prospective Studies
Exercise
Pharmaceutical Preparations

Keywords

  • Cancer patients
  • Cardiotoxicity
  • Cold pressor test
  • Ejection fraction
  • Radionuclide angiography

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Pharmacology (medical)
  • Oncology
  • Medicine(all)

Cite this

The cold pressor test during radionuclide ventriculography : A feasibility study in cancer patients. / Verwey, J.; Van Lingen, A.; Teule, J. J.; Heidendal, G. A K; Pinedo, H. M.

In: Medical Oncology and Tumor Pharmacotherapy, Vol. 3, No. 1, 03.1986, p. 11-14.

Research output: Contribution to journalArticle

Verwey, J. ; Van Lingen, A. ; Teule, J. J. ; Heidendal, G. A K ; Pinedo, H. M. / The cold pressor test during radionuclide ventriculography : A feasibility study in cancer patients. In: Medical Oncology and Tumor Pharmacotherapy. 1986 ; Vol. 3, No. 1. pp. 11-14.
@article{0449c99c503a43c7979db9e3188b542a,
title = "The cold pressor test during radionuclide ventriculography: A feasibility study in cancer patients",
abstract = "To monitor the use of cardiotoxic drugs, adequate assessment of myocardial function is required. Although serial radionuclide left ventricular ejection fraction (EF) studies allow a simple and rapid assessment of the myocardial function without risk or discomfort to the patient, they appear not to be sensitive enough. Determination of the EF during cold application may be more sensitive. In this study we tested the feasibility of the cold pressor test (CPT) in relation to EF determination in 23 cancer patients. Only minor side effects were recorded. The response of heart rate to cold was similar to the response reported in healthy volunteers and patients with coronary artery disease. In selected cases EF determination during CPT appeared to be more sensitive than EF at rest. EFCPT may be an attractive alternative for EFexercise in cancer patients who cannot perform enough exercise to stress cardiac function adequately, but for a more definite conclusion a prospective comparative study is required.",
keywords = "Cancer patients, Cardiotoxicity, Cold pressor test, Ejection fraction, Radionuclide angiography",
author = "J. Verwey and {Van Lingen}, A. and Teule, {J. J.} and Heidendal, {G. A K} and Pinedo, {H. M.}",
year = "1986",
month = "3",
doi = "10.1007/BF02934570",
language = "English (US)",
volume = "3",
pages = "11--14",
journal = "Medical Oncology",
issn = "1357-0560",
publisher = "Humana Press",
number = "1",

}

TY - JOUR

T1 - The cold pressor test during radionuclide ventriculography

T2 - A feasibility study in cancer patients

AU - Verwey, J.

AU - Van Lingen, A.

AU - Teule, J. J.

AU - Heidendal, G. A K

AU - Pinedo, H. M.

PY - 1986/3

Y1 - 1986/3

N2 - To monitor the use of cardiotoxic drugs, adequate assessment of myocardial function is required. Although serial radionuclide left ventricular ejection fraction (EF) studies allow a simple and rapid assessment of the myocardial function without risk or discomfort to the patient, they appear not to be sensitive enough. Determination of the EF during cold application may be more sensitive. In this study we tested the feasibility of the cold pressor test (CPT) in relation to EF determination in 23 cancer patients. Only minor side effects were recorded. The response of heart rate to cold was similar to the response reported in healthy volunteers and patients with coronary artery disease. In selected cases EF determination during CPT appeared to be more sensitive than EF at rest. EFCPT may be an attractive alternative for EFexercise in cancer patients who cannot perform enough exercise to stress cardiac function adequately, but for a more definite conclusion a prospective comparative study is required.

AB - To monitor the use of cardiotoxic drugs, adequate assessment of myocardial function is required. Although serial radionuclide left ventricular ejection fraction (EF) studies allow a simple and rapid assessment of the myocardial function without risk or discomfort to the patient, they appear not to be sensitive enough. Determination of the EF during cold application may be more sensitive. In this study we tested the feasibility of the cold pressor test (CPT) in relation to EF determination in 23 cancer patients. Only minor side effects were recorded. The response of heart rate to cold was similar to the response reported in healthy volunteers and patients with coronary artery disease. In selected cases EF determination during CPT appeared to be more sensitive than EF at rest. EFCPT may be an attractive alternative for EFexercise in cancer patients who cannot perform enough exercise to stress cardiac function adequately, but for a more definite conclusion a prospective comparative study is required.

KW - Cancer patients

KW - Cardiotoxicity

KW - Cold pressor test

KW - Ejection fraction

KW - Radionuclide angiography

UR - http://www.scopus.com/inward/record.url?scp=0022616755&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022616755&partnerID=8YFLogxK

U2 - 10.1007/BF02934570

DO - 10.1007/BF02934570

M3 - Article

C2 - 3702506

AN - SCOPUS:0022616755

VL - 3

SP - 11

EP - 14

JO - Medical Oncology

JF - Medical Oncology

SN - 1357-0560

IS - 1

ER -